Breast cancer, Secondary cancers
Results
Phase 1/2
This trial was for people with breast cancer that had grown outside the breast (locally advanced) or spread to other parts of the body (metastatic).
It was for people whose cancer:
got worse despite treatment with chemotherapy and Herceptin
had receptors for a protein called HER2 ()
Recruitment start: 11 January 2011
Recruitment end: 15 May 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Anthony Kong
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 16 Jul 2018
CRUK internal database number: 7395
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
